Europe to invest USD5.05 billion in commercialization of bio-based products

In July 2013, Novozymes revealed that the European Commission would set up a Public Private Partnership with 48 companies in Europe, and they would jointly invest USD5.05 billion (EUR3.8 billion) in the commercialization of bio-based products from 20...

Biomaterials China News 201308

www.cnchemicals.com